CHEBI:74895 - 223RaCl2

ChEBI IDCHEBI:74895
ChEBI Name223RaCl2
Stars
ASCII Name(223)RaCl2
DefinitionA radium molecular entity with formula 223RaCl2. Used as as a radiotherapeutic agent for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease. An alpha-emitter, radium-223 has a half-life of 11.4 days.
Last Modified30 January 2018
SubmitterSteve
DownloadsMolfile
FormulaCl2
Net Charge0
Average Mass293.925
Monoisotopic Mass292.95621
SMILES[Cl][223Ra][Cl]
InChIInChI=1S/2ClH.Ra/h2*1H;/q;;+2/p-2/i;;1-3
InChIKeyRWRDJVNMSZYMDV-SIUYXFDKSA-L
Wikipedia
Roles Classification
Applications:
radiopharmaceutical  Any pharmaceutical compound containing a radioisotope.
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
ChEBI Ontology
Outgoing Relation(s)
223RaCl2 (CHEBI:74895) has role antineoplastic agent (CHEBI:35610)
223RaCl2 (CHEBI:74895) has role radiopharmaceutical (CHEBI:35232)
223RaCl2 (CHEBI:74895) is a inorganic chloride (CHEBI:36093)
223RaCl2 (CHEBI:74895) is a isotopically modified compound (CHEBI:139358)
223RaCl2 (CHEBI:74895) is a radium molecular entity (CHEBI:37201)
IUPAC Name 
(223Ra)radium dichloride
Synonym  Source
Radium-223 dichlorideKEGG DRUG
Brand Name  Source
XofigoKEGG DRUG
Manual XrefsDatabases
D10398KEGG DRUG
Radium-223_chlorideWikipedia
Registry NumbersSources
CAS:444811-40-9KEGG DRUG
CAS:444811-40-9ChemIDplus
Citations